Vitti Labs Announces FDA Approval of Phase II IND Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Pulmonary Fibrosis Secondary to Novel Corona Virus Infection (COVID-19)
LIBERTY, Mo., May 2, 2022 /PRNewswire/ — Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has approved their Investigational New Drug Application (IND) to move forward with Phase II Outpatient Clinical Trial using a combination of Umbilical Cord […]
BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y., April 29, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage biopharmaceutical company focused on stem cell-based therapies, today announced that it is hosting a Principal Investigators Meeting in Uniondale, NY on April 29th – 30th, 2022 for the Company’s lead clinical candidate BRTX-100®, an autologous bone […]
Be The Match: How you can donate plasma, stem cells to help cancer patients
Good Day Philadelphia shares Fox 29’s sports anchor, Breland Moore’s story of how she donated her plasma and bone marrow stem cells to help a man with cancer. This was all done through Be The Match – an incredible organization that manages the most diverse marrow registry in the world to help patients with life-threatening […]
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
AUSTIN, Texas, April 26, 2022 /PRNewswire/ — Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct […]
NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center
GAITHERSBURG, Md., April 26, 2022 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a preclinical research collaboration with Columbia University Irving Medical Center’s (CUIMC) Herbert Irving Comprehensive Cancer Center (HICCC). The […]
What Are Stem Cells and What Can They Do?
Here’s a very simply and animated explanation of what stem cells are and what they are capable of doing. What Are Stem Cells? Stem Cells When hearing the two words together: ‘stem cells’, most of us would think of cells residing inside the stem of plants. But in reality, stem cells are cells that divide […]
Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product
PHOENIX, April 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced progress in developing a reproducible clinical grade product of ImmCelz®. Multiple clinical experiments were performed in which […]
bit.bio’s Game-Changing Technology for Reprogramming Stem Cells
In this episode of Vital Science, Mark Kotter and his team at bit.bio have an innovative solution to help create consistent and scalable human cells to help researchers study diseases – by “reprogramming” stem cells. Video Transcription: – [Mark Kotter] What’s unique about bit.bio, is not really the use of these pluripotent stem cells, it’s […]
BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y.,, April 18, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it has selected 10 of its 15 clinical sites for its Phase 2 clinical trial targeting chronic lumbar disc disease. BioRestorative’s Phase 2 trial is a […]
How Cells Become Specialized
Have you ever wondered how cells become specialized? How does a neuron or a muscle cell have the structure and function they have? I mean, can you imagine if they had to switch jobs for a day? That…wouldn’t go so well. They’re so specialized for the function they perform. Well this video is going to […]